NATCO Pharma LimitedNSE: NATCOPHARM

Press Release Feb 05 2021

· Issued by NATCO Pharma Limited

Filed with NSE · · 2 pages · English

Summary by 6ix AI

This approval was granted by the Central Insecticide Board & Registration Committee, making NATCO the first indigenous manufacturer of this product. Chlorantraniliprole is used in broad-spectrum insecticides for pest management in various crops, and NATCO plans to make it accessible to farmers in India. The company also notes a pending litigation against FMC regarding the use of Chlorantraniliprole.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Natco Pharma Limited has informed the Exchange regarding a press release dated February 05, 2021, titled "NATCO receives approval for Chlorantraniliprole (CTPR)- 1st key product of Crop Health Sciences Division".

NATCO Pharma Limited on 6ix

Earlier from NATCO Pharma

Later from NATCO Pharma

All NATCO Pharma news releases